NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that its management will be presenting at the following upcoming investor conferences:
- Jefferies 2019 Healthcare Conference in New York, NY at 9:00 a.m. ET on Thursday, June 6, 2019
- Goldman Sachs 40th Annual Global Healthcare Conference in Rancho Palos Verdes, CA at 1:20 p.m. PT on Wednesday, June 12, 2019
- Raymond James Life Sciences and MedTech Conference in New York, NY at 10:55 a.m. ET on Tuesday, June 18, 2019
Webcast information for these events will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. Archived webcasts will be available on Intercept’s website for approximately two weeks.
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.
For more information about Intercept, please contact: